These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34485233)

  • 1. Screening High-Risk Groups and the General Population for SARS-CoV-2 Nucleic Acids in a Mobile Biosafety Laboratory.
    Guo Z; Li L; Song Y; Xu J; Huang J
    Front Public Health; 2021; 9():708476. PubMed ID: 34485233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis.
    Karthik K; Aravindh Babu RP; Dhama K; Chitra MA; Kalaiselvi G; Alagesan Senthilkumar TM; Raj GD
    Arch Med Res; 2020 Oct; 51(7):623-630. PubMed ID: 32948378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China.
    Yuan D; Gao W; Liang S; Yang S; Jia P
    Environ Int; 2020 Oct; 143():105964. PubMed ID: 32768807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic.
    Zhang Y; Gong Y; Wang C; Liu W; Wang Z; Xia Z; Bu Z; Lu H; Sun Y; Zhang X; Cao Y; Yang F; Su H; Hu Y; Deng Y; Zhou B; Zhao Z; Fu Y; Kargbo D; Dafae F; Kargbo B; Kanu A; Liu L; Qian J; Guo Z
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005622. PubMed ID: 28505171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.
    Kaufer AM; Theis T; Lau KA; Gray JL; Rawlinson WD
    Pathology; 2020 Dec; 52(7):790-795. PubMed ID: 33070960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory management for large-scale population screening for SARS-CoV-2.
    Duan X; Lv D; Wang L; Liu Y; Zhang S; Liu W; Xie J; Gu C; Li X; Tao Z; Chen X; Yao Q
    Immun Inflamm Dis; 2022 Jan; 10(1):33-42. PubMed ID: 34808034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosafety risk assessment and risk control of clinical laboratory in designated hospitals for treating COVID-19 in Chongqing, China.
    Long Y; Chang F; Yang F; Hou Y; Mo Z; Diao Q
    Am J Infect Control; 2022 Sep; 50(9):999-1005. PubMed ID: 35671845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
    Wang K; Zhu X; Xu J
    Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment].
    Yuan XN; Meng QY; Shen N; Li YX; Liang C; Cui M; Ge QG; Li XG; Tan K; Chen Q; Wang J; Zeng XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):803-808. PubMed ID: 33047711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and application of biological safety cabinets in diagnostic and research laboratories with special emphasis on COVID-19.
    Pawar SD; Khare AB; Keng SS; Kode SS; Tare DS; Singh DK; More RL; Mullick J
    Rev Sci Instrum; 2021 Aug; 92(8):081401. PubMed ID: 34470433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis to explain unknown causes of the origins of SARS-COV-2.
    Coccia M
    Environ Res; 2022 Aug; 211():113062. PubMed ID: 35259407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portable RT-PCR System: a Rapid and Scalable Diagnostic Tool for COVID-19 Testing.
    Zowawi HM; Alenazi TH; AlOmaim WS; Wazzan A; Alsufayan A; Hasanain RA; Aldibasi OS; Althawadi S; Altamimi SA; Mutabagani M; Alamri M; Almaghrabi RS; Al-Abdely HM; Memish ZA; Alqahtani SA
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33674285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.
    Wu J; Liu J; Li S; Peng Z; Xiao Z; Wang X; Yan R; Luo J
    Travel Med Infect Dis; 2020; 37():101673. PubMed ID: 32311437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
    Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
    Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.
    Islam SRU; Akther T; Sultana S; Deb P; Ghosh AK; Nasif MAO; Bhuiyan AH; Jahan M; Nessa A; Munshi SU; Tabassum S
    J Infect Dev Ctries; 2021 Dec; 15(12):1833-1837. PubMed ID: 35044940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
    Gupta N; Potdar V; Praharaj I; Giri S; Sapkal G; Yadav P; Choudhary ML; Dar L; Sugunan AP; Kaur H; Munivenkatappa A; Shastri J; Kaveri K; Dutta S; Malhotra B; Jain A; Nagamani K; Shantala GB; Raut S; Vegad MM; Sharma A; Choudhary A; Brijwal M; Balakrishnan A; Manjunatha J; Pathak M; Srinivasan S; Banu H; Sharma H; Jain P; Sunita P; Ambica R; Fageria B; Patel D; Rajbongshi G; Vijay N; Narayan J; Aggarwal N; Nagar A; Gangakhedkar RR; Abraham P
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):216-225. PubMed ID: 32242875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention and control of SARS-CoV-2 infection in clinical laboratories: implementation of contingency plan and postpandemic response strategies].
    Hang J; Sun Z; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):606-608. PubMed ID: 32895124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.
    Mohanty S; Ravindra A; Gupta K; Hallur V; Behera B; Mahaptra A; Saha S; Ranjan J; Payal P; Mohanty M; Rath S; Mishra B
    J Med Virol; 2021 May; 93(5):2799-2804. PubMed ID: 33085120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.